Value of top 10 yet to close pharmaceutical deals Q1 2017

This statistic displays the top 10 yet to close pharmaceutical deals worldwide based on value announced in the first quarter of 2017. Johnson & Johnson has bid a deal for Actelion valued at 30 billion U.S. dollars.

Top 10 yet-to-close pharmaceutical deals worldwide based on value announced in the first quarter of 2017 (in billion U.S. dollars)*

Exclusive Premium statistic

You need a Single Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Single Account

only $59 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in
Sources

Release date

May 2017

Region

Worldwide

Survey time period

Q1 2017

Supplementary notes

* Deals can also include M&As of parts/segments/divisions of companies.
Pharmaceutical subsectors include: medicinal chemical & botanical products; pharmaceutical preparations; in vivo and in vivo diagnosistic substances; biotechnology - biological products, except diagnostic substances; and pharmaceutical wholesale (added starting in Q2 2014).

Open this statistic in...
Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Single Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.

Statistics on "Pharmaceutical trends in Europe"

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.